Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Trupanion to Present at the 2019 Canaccord Genuity Growth Conference
-
Harpoon Therapeutics to Participate in Two Upcoming Investor Conferences
-
Cortexyme to Present at the Canaccord Genuity Growth Conference on August 7th
-
RADA to Present at the Canaccord Genuity Growth Conference
-
CannabisNewsWire Recaps BTN’s Highly Anticipated Cannabis Drinks Expo
-
Alphatec Holdings (ATEC) Prices 10.9M Share Offering of Common Stock at $4.60/Share
-
Alphatec Holdings, Inc. Announces Pricing of Public Offering of Common Stock
-
Quanterix to Present at the Canaccord Genuity 39th Annual Growth Conference
-
MRI Software Acquires AI Real Estate Pioneer LEVERTON to Turn Unstructured Data into Business Insights
-
Catasys to Present at the Canaccord Genuity 39th Annual Growth Conference
-
Savara to Present at the 39th Annual Canaccord Genuity Global Growth Conference
-
Forty Seven Inc. to Present at Canaccord Genuity 39th Annual Growth Conference
-
Forty Seven Inc. to Present at Canaccord Genuity 39th Annual Growth Conference
-
Selecta Biosciences to Present at Canaccord Genuity’s 39th Annual Growth Conference on August 7, 2019
-
BioXcel Therapeutics to Present at the Canaccord Genuity 2019 Annual Growth Conference
-
Kaleido Biosciences to Present at the 39th Annual Canaccord Genuity Growth Conference
-
Avid Technology to Present at Upcoming Investor Conferences
-
Kaleido Biosciences to Present at the 39th Annual Canaccord Genuity Growth Conference
-
Pear Therapeutics to Present at Canaccord Genuity 39th Annual Growth Conference
-
SCYNEXIS, Inc. to Present at the 39th Annual Canaccord Genuity Global Growth Conference
-
NAPCO Security Technologies to Present at the Canaccord Genuity Growth Conference on August 7, 2019
-
Zynerba Pharmaceuticals to Present at Two Upcoming Conferences
-
Sesen Bio to Present at the Canaccord Genuity 39th Annual Growth Conference
-
Zendesk (ZEN) PT Raised to $105 at Canaccord Genuity
-
T2 Biosystems, Inc (TTOO) PT Lowered to $2.50 at Canaccord Genuity
-
Mercury Computer (MRCY) PT Raised to $80 at Canaccord Genuity
-
IPG Photonics (IPGP) PT Lowered to $150 at Canaccord Genuity
-
Ecolab Inc. (ECL) PT Raised to $222 at Canaccord Genuity
-
Castlight Health Inc. (CSLT) PT Lowered to $4 at Canaccord Genuity
-
Ceridian HCM Holding Inc. (CDAY) PT Raised to $55 at Canaccord Genuity
-
CRISPR Therapeutics to Present at Upcoming Investor Conferences
-
Cubic to Present at the Canaccord Genuity 39th Annual Growth Conference
-
Caris Life Sciences to Present at Canaccord Genuity Annual Growth Conference
-
Apple (AAPL) PT Raised to $240 at Canaccord Genuity
-
Orasure Technologies to Present at the 39th Annual Canaccord Genuity Growth Conference
-
Orasure Technologies to Present at the 39th Annual Canaccord Genuity Growth Conference
-
Secure Energy Services Inc. (SES:CN) (SECYF) PT Lowered to Cdn$9.50 at Canaccord Genuity
-
Ceridian HCM Holding Inc. (CDAY) PT Raised to $55 at Canaccord Genuity
-
Canaccord Genuity Downgrades Tullow Oil Plc. (TLW:LN) (TUWOY) to Spec. Buy
-
Canaccord Genuity Upgrades Redbubble Ltd. (RBL:AU) (RDBBF) to Buy
-
Air Canada (AC:CN) (ACDVF) PT Raised to Cdn$55 at Canaccord Genuity
-
Aileron Therapeutics to Present at the Canaccord Genuity 39th Annual Growth Conference
-
Voyager Therapeutics to Present at Upcoming Investor Conferences in August 2019
-
Vapotherm (VAPO) Announces Proposed Public Offering of Common Stock
-
Alphatec Holdings (ATEC) Announces Proposed Public Offering of Common Stock
-
Aspen Aerogels to Present at the Canaccord Genuity Growth Conference
-
Vapotherm Announces Proposed Public Offering of Common Stock
-
Alphatec Holdings, Inc. Announces Proposed Public Offering of Common Stock
-
T2 Biosystems Reports Second Quarter 2019 Financial Results and Provides Corporate Update
-
LeMaitre Vascular to Present at the Canaccord Genuity Annual Growth Conference on Thursday, August 8, 2019

